Latest News and Press Releases
Want to stay updated on the latest news?
-
SEATTLE, May 11, 2021 (GLOBE NEWSWIRE) -- OncoResponse, a biotechnology company harnessing the power of the human immune system to identify and develop novel monoclonal antibodies to...
-
- New capital will fund lead antibody, OR2805, through Phase 1 and 2 clinical studies - Adds Magnetar Group, Yonjin Ventures and Bering Capital to the syndicate SEATTLE, March 31, 2021 (GLOBE...